Form 4: Tango Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Jessica Newcomb, Principal Accounting Officer of Tango Therapeutics, Inc., sold 8,200 shares of common stock on September 22, 2026.
Summary
- Open-market sale: disposed of 700 Common Stock at $22.80 ($15,962) on September 22, 2026; holds 66,621 after (Direct).
- Open-market sale: disposed of 5,100 Common Stock at $23.97 ($122,238) on September 22, 2026; holds 61,521 after (Direct).
- Open-market sale: disposed of 2,400 Common Stock at $25.17 ($60,412) on September 22, 2026; holds 59,121 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $198,613 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jessica Newcomb — Officer (Principal Accounting Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Open-market sale | Common Stock | 700 | $23 | $16.0K | 66,621 |
| 2026-09-22 | Open-market sale | Common Stock | 5,100 | $24 | $122.2K | 61,521 |
| 2026-09-22 | Open-market sale | Common Stock | 2,400 | $25 | $60.4K | 59,121 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Open-market sale (700 shares) |
| 2026-09-22 | Open-market sale (5,100 shares) |
| 2026-09-22 | Open-market sale (2,400 shares) |
Keywords
insider transaction, Form 4, TNGX, Tango Therapeutics, Inc., bearish, Jessica Newcomb
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.